Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis  
Disease area: Paediatric lung diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
A. ARTARAZ (Galdakao (Bizkaia), Spain). Impact of pneumococcal vaccination in children in the distribution of serotypes in bacteriemic pneumococcal pneumonia in adults. 4510

Member's Comments

No comment yet.

Related content which might interest you: The remaining challenges of pneumococcal disease in adults Source: Eur Respir Rev 2012; 21: 57-65 Year: 2012 Characteristics of patients with serotype 5 pneumococcal pneumonia Source: Virtual Congress 2020 – Clinical challenges in pneumonia Year: 2020 Influence of pneumococcal serotype group on outcome in adults with bacteraemic pneumonia Source: Eur Respir J 2010; 36: 1073-1079 Year: 2010 Impact of infant 13-valent pneumococcal conjugate vaccine on serotypes in adult pneumonia Source: Eur Respir J 2015; 45: 1632-1641 Year: 2015 Aetiology of paediatric pneumonia after the introduction of pneumococcal conjugate vaccine Source: Eur Respir J 2013; 42: 1595-1603 Year: 2013 Complicated pneumococcal pneumonia in adults Source: Annual Congress 2009 - Ventilator-associated pneumonia, severe community-acquired pneumonia and healthcare associated pneumonia Year: 2009 A longitudinal analysis of pneumococcal vaccine serotypes in pneumonia patients in Germany Source: Eur Respir J, 59 (2) 2102432; 10.1183/13993003.02432-2021 Year: 2022 Impact of introducing the 10-valent pneumococcal conjugate vaccine on childhood hospitalizations for bacterial pneumonia in Brazil Source: Annual Congress 2013 –Paediatric respiratory epidemiology: bronchiolitis and asthma Year: 2013 Protective effect of pneumococcal vaccine against death by pneumonia in elderly subjects Source: Eur Respir J 2005; 26: 1086-1091 Year: 2005 Risk factors for respiratory failure in pneumococcal pneumonia: the importance of pneumococcal serotypes Source: Eur Respir J 2014; 43: 545-553 Year: 2013 Clinical effectiveness of pneumococcal vaccination against nonbacteremic pneumonia in people over 50 years Source: Annual Congress 2008 - Community-acquired pneumonia: prognosis, complications and prevention Year: 2008 Effectiveness of the pneumococcal polysaccharide vaccine in preventing pneumonia in the elderly Source: Eur Respir J 2010; 36: 608-614 Year: 2010 Influenza and pneumococcal vaccination in patients with COPD Source: Virtual Congress 2020 – Pharmacological management of COPD Year: 2020 Role of pneumococcal vaccine on the incidence of childhood empyema Source: Breathe 2010; 6: 366-367 Year: 2010 Efficacy of influenza and pneumococcal vaccinations among patients with COPD Source: Annual Congress 2007 - Treatment of COPD Year: 2007 Changes in pathogens and pneumococcal serotypes causing community-acquired pneumonia in The Netherlands Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis   Year: 2017 Serotype dynamics in pneumococcal diseases and the performance of vaccination strategies for older adults in germany Source: Virtual Congress 2020 – How do different treatment strategies translate into costs Year: 2020 Perception and uptake of the influenza and pneumococcal vaccinations in patients with COPD Source: Annual Congress 2008 - Organisation of care and management of COPD Year: 2008 Dynamics of serotypic composition of nasopharyngeal pneumococcal isolates in children pneumococcal nasopharyngeal colonization after the introduction of the vaccination program in Moscow Source: Virtual Congress 2020 – Different aspects of paediatric viral and bacterial lung infections Year: 2020